Nanjing Vazyme Biotech Co., Ltd (SHA:688105)
China · Delayed Price · Currency is CNY 23.52
-0.09 (-0.38%)
Jul 16, 2025, 3:00 PM CST
Nanjing Vazyme Biotech Market Cap
Nanjing Vazyme Biotech has a market cap or net worth of 9.39 billion as of July 16, 2025. Its market cap has increased by 14.77% in one year.
Market Cap
9.39B
Enterprise Value
7.57B
Revenue
1.36B
Ranking
n/a
PE Ratio
n/a
Stock Price
23.52
Market Cap Chart
Since November 15, 2021, Nanjing Vazyme Biotech's market cap has decreased from 34.14B to 9.39B, a decrease of -72.49%. That is a compound annual growth rate of -29.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 15, 2025 | 9.39B | 6.58% |
| Dec 31, 2024 | 8.81B | -31.21% |
| Dec 29, 2023 | 12.81B | -39.74% |
| Dec 30, 2022 | 21.26B | -49.87% |
| Dec 31, 2021 | 42.40B | 24.19% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Medicine | 382.38B |
| Shenzhen Mindray Bio-Medical Electronics | 260.09B |
| WuXi AppTec | 228.64B |
| Zhangzhou Pientzehuang Pharmaceutical., | 118.85B |
| Aier Eye Hospital Group | 114.99B |
| Sichuan Biokin Pharmaceutical | 113.84B |
| Shanghai United Imaging Healthcare | 101.76B |
| Yunnan Baiyao Group Co.,Ltd | 99.21B |